Published in Clin Exp Immunol on October 01, 1983
Changes in the populations of lymphoid cells in human peripheral blood following physical exercise. Clin Exp Immunol (1984) 1.03
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon. Clin Exp Immunol (1986) 0.88
Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro. Ann Rheum Dis (1987) 0.85
Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J Virol (1991) 0.81
Altered signaling in systemic juvenile idiopathic arthritis monocytes. Clin Immunol (2015) 0.75
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Heberden Oration, 1977. Chronic arthritis in childhood. Ann Rheum Dis (1978) 2.55
Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum (1982) 2.40
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum (1981) 1.41
Detection of gamma interferon in the sera of patients with Behçet's disease. Infect Immun (1982) 1.33
Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J Natl Cancer Inst (1973) 1.32
Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon. Nature (1977) 1.27
Assay of chick interferons by the inhibition of viral ribonucleic acid synthesis. Appl Microbiol (1971) 1.23
Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J Exp Med (1980) 1.19
Virus and interferon effects on cellular prostaglandin biosynthesis. J Immunol (1980) 1.12
Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. J Gen Virol (1981) 1.10
Prostaglandins and chronic inflammation. Biochem Pharmacol (1978) 1.08
A rapid and simple method for assaying interferon. Jpn J Microbiol (1974) 0.92
Optimization of the interferon assay using inhibition of Semliki forest virus-ribonucleic acid synthesis. Appl Microbiol (1972) 0.83
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
The hypermobility syndrome. Musculoskeletal complaints associated with generalized joint hypermobility. Ann Rheum Dis (1967) 4.99
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature (1979) 2.79
Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann Rheum Dis (1974) 2.77
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl (1987) 2.62
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Heberden Oration, 1977. Chronic arthritis in childhood. Ann Rheum Dis (1978) 2.55
Fluoridation and the rheumatic diseases. A comparison of rheumatism in Watford and Leigh. Ann Rheum Dis (1966) 2.52
Spondylo-epiphysial dysplasia tarda with progressive arthropathy. A "new" disorder of autosomal recessive inheritance. J Bone Joint Surg Br (1982) 2.47
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Raised IgG antiglobulin factors in Still's disease. Ann Rheum Dis (1969) 2.39
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture. Antimicrob Agents Chemother (1987) 2.11
Septic arthritis. Ann Rheum Dis (1972) 2.06
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Steroid cataract. Ann Rheum Dis (1966) 1.93
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum (1974) 1.84
Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother (1992) 1.82
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases. Ann Rheum Dis (1966) 1.78
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Total hip replacement using the McKee-Farrar prosthesis. In rheumatoid arthritis, Still's disease, and ankylosing spondylitis. Ann Rheum Dis (1970) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals. Antimicrob Agents Chemother (1988) 1.57
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Systemic lupus erythematosus in childhood. Ann Rheum Dis (1981) 1.48
Measurement of pain in juvenile chronic polyarthritis. Ann Rheum Dis (1977) 1.47
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet (1988) 1.46
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Pain control with paracetamol from a sustained release formulation and a standard release formulation after third molar surgery: a randomised controlled trial. Br Dent J (2001) 1.44
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
Problem fracture in Paget's disease of bone. J R Soc Med (1989) 1.40
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Live influenza vaccines. Lancet (1983) 1.39
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Picornaviridae. Intervirology (1974) 1.36
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis (1985) 1.33
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
Mortality and prognosis related to the amyloidosis of Still's disease. Ann Rheum Dis (1968) 1.30
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum (1977) 1.28